Patient selection for cytoreduction and hyperthermic intraperitoneal chemoperfusion

Peritoneal Carcinomatosis: A Multidisciplinary Approach

Volumn , Issue , 2007, Pages 215-229

  Stewart, John H ^a   Shen, Perry ^a   Levine, Edward A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

FEMALE; HUMAN; HYPERTHERMIC THERAPY; INFUSION; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATIENT SELECTION; PERITONEUM; PREOPERATIVE CARE; REGIONAL PERFUSION; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MALE; NEOPLASMS; PATIENT SELECTION; PERITONEUM; PREOPERATIVE CARE;

EID: 84892803866     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-48993-3_13     Document Type: Chapter

References (55)

1. Cady B (1990) The Society of Surgical Oncology at a crossroads: thoughts for the future. Presidential address. Arch Surg 125(2):153-157
2. Shen P, Levine EA, Hall J, Case D, Russell G, Fleming R et al (2003) Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 138(1):26-33
3. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G et al (1999) Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6(8):790-796
4. Ahmad SA, Kim J, Sussman JJ, Soldano DA, Pennington LJ, James LE et al (2004) Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion. Ann Surg Oncol 11(4):387-392
5. Dawson LE, Russell AH, Tong D, Wisbeck WM (1983) Adenocarcinoma of the sigmoid colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. J Surg Oncol 22(2):95-99
6. Russell AH, Tong D, Dawson LE, Wisbeck WM, Griffin TW, Laramore GE et al (1983) Adenocarcinoma of the retroperitoneal ascending and descending colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. Int J Radiat Oncol Biol Phys 9(3):361-365
7. Deraco M, Raspagliesi F, Kusamura S (2003) Management of peritoneal surface component of ovarian cancer. Surg Oncol Clin N Am 12(3):561-583
8. Sugarbaker PH, Yonemura Y (2000) Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 58(2):96-107
9. Moertel CG (1972) Peritoneal mesothelioma. Gastroenterology 63(2):346-350
10. Chan PS, Balfour TW, Bourke JB, Smith PG (1975) Peritoneal nesothelioma. Br J Surg 62(7):576-580
11. McQuellon RP, Loggie BW, Fleming RA, Russell GB, Lehman AB, Rambo TD (2001) Quality of life after intraperitoneal hyperthermic chemotherapy (HIPEC) for peritoneal carcinomatosis. Eur J Surg Oncol 27(1):65-73
12. Brenner J, Sordillo PP, Magill GB, Golbey RB (1981) Malignant peritoneal mesothelioma: review of 25 patients. Am J Gastroenterol 75(4):311-313
13. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88(2):358-363
14. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY et al (1996) Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334(1):1-6
15. Antman KH, Osteen RT, Klegar KL, Amato DA, Pomfret EA, Larson DA et al (1985) Early peritoneal mesothelioma: a treatable malignancy. Lancet 2(8462):977-981
16. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM (1995) Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to pseudomyxoma peritonei . Am J Surg Pathol 19(12):1390-1408
17. Sugarbaker PH, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6(8):727-731
18. Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FA (2001) Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 88(3):458-463
19. Elias D, Laurent S, Antoun S, Duvillard P, Ducreux M, Pocard M et al (2003) [Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy]. Gastroenterol Clin Biol 27(4):407-412
20. Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C et al (2004) Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 11(4):393-398
21. Stewart JH, Shen P, Russell GB, Bradley RF, Hundley JC, Loggie BL et al (2006) Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol 13(5):624-634
22. Glehen O, Schreiber V, Cotte E, Sayag-Beaujard AC, Osinsky D, Freyer G et al (2004) Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 139(1):20-26
23. Pestieau SR, Sugarbaker PH (2000) Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis Colon Rectum 43(10):1341-1346
24. Glehen O, Cotte E, Schreiber V, Sayag-Beaujard AC, Vignal J, Gilly FN (2004) Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 91(6):747-754
25. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21(20):3737-3743
26. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M et al (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22(16):3284-3292
27. Hall JJ, Loggie BW, Shen P, Beamer S, Douglas CL, McQuellon R et al (2004) Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 8(4):454-463
28. Yonemura Y, de Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E et al (2001) Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology 48(42):1776-1782
29. Yonemura Y, Fujimura T, Nishimura G, FallaR, Sawa T, Katayama K et al (1996) Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 119(4):437-444
30. Deraco M, Rossi CR, Pennacchioli E, Guadagni S, Somers DC, Santoro N et al (2001) Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study. Tumori 87(3):120-126
31. Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR, Levine EA (2001) Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg 67(10):999-1003
32. Costamagna D, Scuderi S, Vaira M, Barone R, De Simone M (2003) [Treatment of peritoneal mesothelioma using cytoreduction and intraperitoneal hyperthermic chemotherapy]. Tumori 89(4 Suppl):40-42
33. Sugarbaker PH, Welch LS, Mohamed F, Glehen O (2003) A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 12(3):605-21, xi
34. Park BJ, Alexander HR, Libutti SK, Wu P, Royalty D, Kranda KC et al (1999) Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP). Ann Surg Oncol 6(6):582-590
35. Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R et al (2003) Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J Surg Oncol 83(3):147-153
36. Feldman AL, Libutti SK, Pingpank JF, Bartlett DL, Beresnev TH, Mavroukakis SM et al (2003) Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 21(24):4560-4567
37. Berthet B, Sugarbaker TA, Chang D, Sugarbaker PH (1999) Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur J Cancer 35(3):413-419
38. Kinsella TJ, Sindelar WF, Lack E, Glatstein E, Rosenberg SA (1988) Preliminary results of a randomized study of adjuvant radiation therapy in resectable adult retroperitoneal soft tissue sarcomas. J Clin Oncol 6(1):18-25
39. Karakousis CP, Gerstenbluth R, Kontzoglou K, Driscoll DL (1995) Retroperitoneal sarcomas and their management. Arch Surg 130(10):1104-1109
40. Pirayesh A, Chee Y, Helliwell TR, Hershman MJ, Leinster SJ, Fordham MV et al (2001) The management of retroperitoneal soft tissue sarcoma: a single institution experience with a review of the literature. Eur J Surg Oncol 27(5):491-497
41. Rossi CR, Deraco M, De Simone M, Mocellin S, Pilati P, Foletto M et al (2004) Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical out-come and prognostic factors in 60 consecutive patients. Cancer 100(9):1943-1950
42. Shen P, Hawksworth J, Lovato J, Loggie BW, Geisinger KR, Fleming RA et al (2004) Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 11(2):178-186
43. Loggie BW, Perini M, Fleming RA, Russell GB, Geisinger K (1997) Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy. Am Surg 63(2):137-143
44. de Bree E, Koops W, Kroger R, van Ruth S, Witkamp AJ, Zoetmulder FA (2004) Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86(2):64-73
45. Kubik-Huch RA, Dorffler W, von Schulthess GK, Marincek B, Kochli OR, Seifert B et al (2000) Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. Eur Radiol 10(5):761-767
46. Low RN, Barone RM, Lacey C, Sigeti JS, Alzate GD, Sebrechts CP (1997) Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 204(2):513-520
47. Rose PG, Faulhaber P, Miraldi F, Abdul-Karim FW (2001) Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy. Gynecol Oncol 82(1):17-21
48. Culliford AT, Brooks AD, Sharma S, Saltz LB, Schwartz GK, O 'Reilly EM et al (2001) Surgical debulking and intraperitoneal chemotherapy for esta blished peritoneal metastases from colon and appendix cancer. Ann Surg Oncol 8(10):787-795
49. Marcus EA, Weber TK, Rodriguez-Bigas MA, Driscoll D, Meropol NJ, Petrelli NJ (1999) Prognostic factors affecting survival in patients with colorectal carcinomatosis. Cancer Invest 17(4):249-252
50. Glehen O, Mithieux F, Osinsky D, Beaujard AC, Freyer G, Guertsch P et al (2003) Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol 21(5):799-806
51. Yonemura Y, Fujimura T, Fushida S, Fujita H, Bando E, Nishimura G et al (1999) A new surgical approach (peritonectomy) for the treatment of peritoneal dissemination. Hepatogastroenterology 46(25):601-609
52. McQuellon RP, Loggie BW, Lehman AB, Russell GB, Fleming RA, Shen P et al (2003) Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 10(2):155-162
53. Alexander HR, Mavroukakis SM, Libutti SK, Pingpank JF, Beresnev TH, Marden S et al (2004) Impact of Tumor Resection and Intraperitoneal Chemotherapy on Health Related Quality of Life in Patients with Peritoneal Surface Malignancies. Proceedings of the 57th Annual Society of Surgical Oncology (SSO) Cancer Symposium
54. Portilla AG, Sugarbaker PH, Chang D (1999) Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg 23(1):23-29
55. Levine EA (2004) Problems of success and problems of failure: recurrent disease after cytoreductive surgery and intraperitoneal chemoperfusion. Ann Surg Oncol 11(4):351-353